These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27717262)

  • 1. Abandoning personalization to get to precision in the pharmacotherapy of depression.
    Perlis RH
    World Psychiatry; 2016 Oct; 15(3):228-235. PubMed ID: 27717262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical characterization of the adult patient with depression aimed at personalization of management.
    Maj M; Stein DJ; Parker G; Zimmerman M; Fava GA; De Hert M; Demyttenaere K; McIntyre RS; Widiger T; Wittchen HU
    World Psychiatry; 2020 Oct; 19(3):269-293. PubMed ID: 32931110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural and neuroendocrine predictors of pharmacological treatment response in adolescents with depression: A preliminary study.
    Klimes-Dougan B; Westlund Schreiner M; Thai M; Gunlicks-Stoessel M; Reigstad K; Cullen KR
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():194-202. PubMed ID: 29100972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.
    Jha MK; Trivedi MH
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29329256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General Predictors and Moderators of Depression Remission: A VAST-D Report.
    Zisook S; Johnson GR; Tal I; Hicks P; Chen P; Davis L; Thase M; Zhao Y; Vertrees J; Mohamed S
    Am J Psychiatry; 2019 May; 176(5):348-357. PubMed ID: 30947531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
    JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MAKE Biomarker Discovery for Enhancing anTidepressant Treatment Effect and Response (MAKE BETTER) Study: Design and Methodology.
    Kang HJ; Kim JW; Kim SY; Kim SW; Shin HY; Shin MG; Kim JM
    Psychiatry Investig; 2018 May; 15(5):538-545. PubMed ID: 29614851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.
    Trivedi MH; McGrath PJ; Fava M; Parsey RV; Kurian BT; Phillips ML; Oquendo MA; Bruder G; Pizzagalli D; Toups M; Cooper C; Adams P; Weyandt S; Morris DW; Grannemann BD; Ogden RT; Buckner R; McInnis M; Kraemer HC; Petkova E; Carmody TJ; Weissman MM
    J Psychiatr Res; 2016 Jul; 78():11-23. PubMed ID: 27038550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.
    Phillips ML; Chase HW; Sheline YI; Etkin A; Almeida JR; Deckersbach T; Trivedi MH
    Am J Psychiatry; 2015 Feb; 172(2):124-38. PubMed ID: 25640931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomic testing and personalized treatment of depression.
    Perlis RH
    Clin Chem; 2014 Jan; 60(1):53-9. PubMed ID: 24281779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder.
    Smagula SF; Wallace ML; Anderson SJ; Karp JF; Lenze EJ; Mulsant BH; Butters MA; Blumberger DM; Diniz BS; Lotrich FE; Dew MA; Reynolds CF
    J Psychiatr Res; 2016 Oct; 81():112-8. PubMed ID: 27438687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
    Kircanski K; Williams LM; Gotlib IH
    Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.